Clinical Trial Update: Study of the Efficacy and Safety of SCH 486757 in Subjects With Chronic Cough (Study P04887) [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 trial evaluating the efficacy and safety of SCH 486757 in adults with chronic cough.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cough

Drugs mentioned

• SCH 486757

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Cough | Phase 2 | Status: COMPLETED